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Hsp70 promotes TNF-mediated apoptosis
by binding IKK␥ and impairing NF-B
survival signaling
Ruiqiong Ran,1,6 Aigang Lu,1 Lu Zhang,2 Yang Tang,1 Hongyan Zhu,1 Huichun Xu,1 Yuxin Feng,2
Chun Han,3 Guoping Zhou,4 Alan C. Rigby,4 and Frank R. Sharp1
1
Departments of Neurology, Pediatric Neurology and the Neurosciences Program, 2Department of Cell Biology,
Neurobiology and Anatomy, and 3Cincinnati Children’s Hospital and Medical Center, University of Cincinnati, Cincinnati,
Ohio 45267, USA; 4Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston,
Massachusetts 02115, USA

The major heat shock protein, Hsp70, can protect against cell death by directly interfering with mitochondrial
apoptosis pathways. However, Hsp70 also sensitizes cells to certain apoptotic stimuli like TNF. Little is
known about how Hsp70 enhances apoptosis. We demonstrate here that Hsp70 promotes TNF killing by
specifically binding the coiled-coil domain of IB kinase ␥ (IKK␥) to inhibit IKK activity and consequently
inhibit NF-B-dependent antiapoptotic gene induction. An IKK␥ mutant, which interacts with Hsp70,
competitively inhibits the Hsp70–IKK␥ interaction and relieves heat-mediated NF-B suppression. Depletion
of Hsp70 expression with RNA interference rescues TNF-mediated cell death. Although TNF may or may not
be sufficient to trigger apoptosis on its own, TNF-triggered apoptosis was initiated or made worse when Hsp70
expression increased to high levels to disrupt NF-B signaling. These results provide significant novel insights
into the molecular mechanism for the pro-apoptotic behavior of Hsp70 in death-receptor-mediated cell death.
[Keywords: Hsp70; NF-B; IKK␥; TNF; apoptosis; death receptor signaling]
Received January 21, 2004; revised version accepted March 30, 2004.

Even though heat shock proteins are known to inhibit
various types of apoptosis, some studies show that heat
or elevated heat shock protein 70 (Hsp70) also potentiates cell death following specific stimuli. For instance,
overexpression of HSF1 (heat shock transcription factor
1, one transcription factor that controls the heat shock
response) enhances Fas-induced cell apoptosis (Xia et al.
2000). Elevated Hsp70 promotes TCR/CD3- and Fas/
Apo-1/CD95-mediated Jurkat T-cell apoptosis (Liossis et
al. 1997). Heat increases cell death following some chemotherapeutics and radiation (Dewey 1984), and heat
shock also sensitizes AML cells and endothelial cells to
apoptosis (Chant et al. 1996; DeMeester et al. 1998).
Hsp70 inhibits cellular proliferation (Maheswaran et al.
1998). Moreover, it is also well established that heat
shock or elevated Hsp70 alters the regulation of signaling cascades and transcription factors and potently sensitizes tumors to radiation (Curry et al. 1999). These results imply that heat or Hsp70 could disable a cell survival signal under the appropriate circumstances.
NF-B is sequestered in the cytoplasm in an inactive
complex with IB proteins (Huxford et al. 1998; Malek et
6
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al. 2001). Activation of the NF-B-mediated signal is initiated through degradation of phosphorylated IB. Various stimuli activate the IB kinase (IKK) complex, which
in turn phosphorylates IB, leading to NF-B activation
(Chen et al. 1995; Zandi et al. 1997). NF-B is critical for
survival of most cells through the induction of antiapoptotic genes (Beg et al. 1995; Beg and Baltimore 1996;
Van Antwerp et al. 1996; Wang et al. 1998; Zong et al.
1999; Rudolph et al. 2000). IKK plays a central role in
mediating NF-B activation. IKK is composed of two
catalytic subunits, IKK␣ and IKK␤, which can directly
phosphorylate IB. IKK␥ (also called NEMO) is an absolutely essential regulatory component of the IKK complex that is necessary for NF-B activation (Rothwarf et
al. 1998; Yamaoka et al. 1998; Makris et al. 2002).
A number of studies have also shown that heat shock
or elevated Hsp70 suppresses NF-B activity (Feinstein
et al. 1997; Guzhova et al. 1997; Curry et al. 1999; Andres et al. 2002; Malhotra and Wong 2002). Although
these studies imply the possibility that Hsp70 impairs
NF-B signaling, the exact molecular basis of the Hsp70
and NF-B interaction is still enigmatic.
This study therefore examined the mechanism by
which Hsp70 interacts with NF-B and might promote
apoptosis. To do this, we studied several cell lines (Cos1, Hela, 293 cells) that do not apparently undergo apo-
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ptosis when exposed to TNF alone. However, when
these cells are exposed to TNF in combination with
Hsp70 overexpression or heat shock, they die via apoptosis. Here, we demonstrate that Hsp70 associates directly
and specifically with IKK␥ and blocks the formation of
the IKK complex—possibly by inhibiting oligomerization of IKK␥. This inhibits TNF-triggered NF-B activation and subsequently prevents NF-B-dependent antiapoptotic gene expression. This work demonstrates how
Hsp70 promotes rather than inhibits TNF-mediated cell
death.

Results
Hsp70 inhibits NF-B activity
To determine whether Hsp70 itself specifically suppressed NF-B activity, we cotransfected Cos-1 cells
with an NF-B reporter and the indicated constructs. In
this transfection assay, Hsp70 and IB␣DN (IB␣ dominant negative) suppressed NF-B reporter gene activity,
whereas Hsp70C (C terminus of Hsp70) and Hsp70N (N
terminus of Hsp70) failed to do so (Fig. 1A). HSF1 also
inhibited NF-B activity. However, this inhibition was
abrogated by cotransfection with Hsp70AS (antisense
Hsp70), indicating that HSF1 did not directly affect NFB activity (Fig. 1A). Hsp90 did not affect NF-B activity
in resting cells but enhanced NF-B activity when cells
were treated with TNF (Fig. 1A).
To demonstrate the specificity of the Hsp70 inhibition, we did similar experiments with AP-1- and HSFdependent reporters. It was shown that Hsp70 did not
significantly affect activation of AP-1, whereas both
Hsp70 and Hsp70C efficiently inhibited HSF activity
(Fig. 1B). This is consistent with findings that Hsp70 can
inhibit HSF1 transcriptional activity (Abravaya et al.
1992; Shi et al. 1998). An additional control experiment
showed that Hsp70 had similar effects on the refolding of
␤-gal and luciferase, as measured by their enzymatic activities (data not shown). Therefore, in all of the transfection assays shown, the elevated Hsp70 did not artificially decrease or increase the luciferase readings when
normalized to ␤-gal.
To determine whether physiologically elevated levels
of Hsp70 inhibit NF-B activity, we established Hsp70inducible cell lines using the nonintegrating plasmid
pMEP4 under the control of a Zn2+-regulated metallothionein promoter. Hsp70 dose-dependently inhibited
NF-B activity (Fig. 1C). The modest reduction of
NF-B activity in Hsp70C-expressing cells (Fig. 1C,
lanes 2–4) likely occurred because of Zn2+-mediated induction of endogenous Hsp70 (Fig. 1C,D). Cells treated
with TNF alone, in the absence of ZnCl2, had a relative
luciferase activity for NFB-luc of 100 ± 8 (see results
following), which is similar to the relative luciferase activity levels for the cells stably expressing His-Hsp70C
in the presence of ZnCl2 (Fig. 1C, lanes 2–4) and for HisHsp70 cells treated with low levels of ZnCl2 (Fig. 1C,
lane 6).

Hsp70 did not directly interfere with the function of
the NF-B activation domain using a cotransfection assay with plasmid encoding Gal4 (DNA-binding domain)p65 (activation domain) chimeric protein, a Gal-4 reporter, and Hsp70 construct (data not shown). Next, to
analyze the effect of Hsp70 on NF-B DNA-binding activity, we performed a gel mobility shift assay using a
p65 probe and nuclear extracts isolated from Cos-1 cells.
Heat, Hsp70, IB␣DN, and HSF1 inhibited NF-B DNA
binding (Fig. 1E, lanes 1–8). The effects of HSF1 were not
a direct effect on the NF-B activity because Hsp70 antisense (Hsp70AS) blocked the effect, showing that it is
HSF1 induction of Hsp70 that inhibits NF-B DNA binding (Fig. 1E, lane 8). Cellular localization data showed
that Hsp70 inhibited TNF-induced translocation of p65
from the cytoplasm to the nucleus (Fig. 1F).
To test whether Hsp70 and HSF1 directly affect the
NF-B DNA-binding activity, we translated p65, Hsp70,
and HSF1 proteins in vitro and performed the aforementioned gel mobility shift assays. Hsp70 and HSF1 failed
to directly influence the NF-B DNA binding (Fig. 1G).
These negative data are shown because they help rule
out the possibility that Hsp70 or HSF1 directly regulates
NF-B DNA-binding activity. In order to further rule out
the possibility that Hsp70 directly interacts with NF-B
(p65), we constructed NLS/p65 plasmids with forced p65
nuclear localization that was independent of IB␣ degradation. Cos-1 cells were cotransfected with NLS/p65,
NF-B reporter, and Hsp70 constructs. NF-B reporter
activity analysis showed that Hsp70 did not suppress
NF-B activity (data not shown). This confirmed the earlier findings that Hsp70 did not directly interact with
NF-B (p65).
Hsp70 inhibits TNF-induced phosphorylation of IB␣
Because Hsp70 inhibited NF-B activity without directly
binding NF-B, this indicated that Hsp70 impaired NFB signaling upstream of NF-B (p65). Because activation
of NF-B requires phosphorylation of IB, we examined
the effects of Hsp70 on the phosphorylation of IB using
specific antibodies to examine phosphorylated and unphosphorylated IB␣ proteins. The results showed that
Hsp70 inhibited TNF-induced IB␣ phosphorylation
(Fig. 2A).
These data suggested either that Hsp70 directly inhibited IB activity, or that Hsp70 directly bound IB␣ to
mask its phosphorylation site, or that Hsp70 accelerated
IB␣ dephosphorylation. In order to differentiate between these possibilities, several experiments were performed. First, pull-down data, immunoprecipitation
data, and two-hybrid experiments showed that Hsp70
did not interact with IB␣ (see data below). Second,
Hsp70- and Hsp70C-inducible Hela cells were transiently transfected with Flag-IKK␣ and Flag-IKK␤. The
effect of Hsp70 on IKK activity was assayed using an in
vitro kinase assay with exogenous GST–IB␣ (1–56) as
the substrate. Hsp70 reduced IKK activity in a dose-dependent manner (Fig. 2B). Neither Hsp70 nor Hsp70C
altered IKK␤ expression (Fig. 2B).
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Figure 1. Hsp70 inhibits NF-B activation. (A) Cos-1 cells were transfected with
the indicated plasmids and the NF-B reporter. Twenty-four hours after transfection, cells were treated with TNF (25 ng/
mL) or vehicle for 15 min. Luciferase activity was measured 24 h later. (B) Effects
of Hsp70 on Ap-1- and HSF-1-dependent
transactivation. Cos-1 cells were cotransfected with an AP-1 or HSF-1 luciferase
reporter along with the indicated vectors.
Twenty-four hours later, cells were treated
with TNF or vehicle for 15 min. After 24
h, luciferase activities were measured. (C)
Hsp70- and Hsp70C-inducible cells were
transiently transfected with an NF-B-dependent luciferase reporter and then
treated with different concentrations of
ZnCl2 for 4 h to induce His-tagged Hsp70
and His-tagged Hsp70C expression. At 16
h after ZnCl2 treatment, cells were treated
with TNF (25 ng/mL) or vehicle for 15
min. NF-B activity was analyzed 24 h after TNF treatment. Hsp70 and Hsp70C expression levels were examined with an
anti-His antibody. ␤-Actin served as the
lane-loading control. (D) Immunoblots of
exogenous and endogenous Hsp70 expression in Hsp70 stable cells were treated
with ZnCl2 (for 4 h). Sixteen hours later,
cell lysates were immunoblotted with
anti-Hsp70 antibody. (E) Cos-1 cells were
transfected with the indicated constructs
and selected cells treated with TNF (25 ng/
mL) for 15 min or heated for 30 min at
45°C. Twenty-four hours later, nuclear extracts were prepared and subjected to a gel
shift assay using a 32P-labeled p65 probe.
(NS) Nonspecific binding. (F) Hsp70- or
Hsp70C-inducible Hela cells were treated
with ZnCl2 (100 µM) or vehicle for 4 h.
Sixteen hours later, cells were treated with
TNF (25 ng/mL) or vehicle for 15 min.
Cells were stained 15 min later with an
anti-p65 antibody and a TRITC-conjugated second antibody. Nuclei were visualized with Hoechst. (G) Gel shift assay
with in vitro translated Hsp70, HSF1, and
p65 proteins and a 32P-labeled p65 probe.
(NS) Nonspecific binding.

Hsp70 directly interacts with IKK␥
On the basis of these observations, we considered
whether Hsp70 directly interacted with one or more
components of the IKK complex and inhibited IKK activity. To determine which molecule(s) of the IKK complex might be the primary target of Hsp70, we searched
for a direct interaction between the three IKKs and
Hsp70 using a beads pull-down assay. 35S-labeled IKK␥
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was retained on Hsp70-, but not on Hsp70C- conjugated
beads. IKK␣ and IKK␤ did not associate with Hsp70 or
with Hsp70C (Fig. 3A).
To map which region within IKK␥ was responsible for
this interaction, we constructed various deletions of
IKK␥ (Fig. 3B). The in vitro beads pull-down assay
showed that only the IKK␥ and IKK␥C1, which contained
the coiled-coil motif, interacted with Hsp70 (Fig. 3C), suggesting that Hsp70 bound to the coiled-coil motif of IKK␥.
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assessed by P-IB␣ levels, decreased (Fig. 3E, top gel)
with decreasing levels of IKK␥ (Fig. 3F, third gel from
top).

Hsp70 inhibits the formation of the IKK complex
Figure 2. Effects of Hsp70 on IB␣ phosphorylation. (A) Hsp70and Hsp70C- inducible Hela cells were induced with 100 µM
ZnCl2 for 4 h. Sixteen hours later, cells were treated with TNF
?25 ng/mL) for 15 min. Protein levels of phospho-IB␣, IB␣, and
␤-actin were examined 15 min after TNF treatment by Western
blot. (B) Hsp70- and Hsp70C-inducible Hela cells were transiently transfected with Flag-IKK␤ and exposed to ZnCl2 (0–125
µM) for 4 h. Sixteen hours later, the cells were treated with TNF
(25 ng/mL) for 15 min. Fifteen minutes later, cells were lysed
and Hsp70 and Hsp70C were immunoblotted with an anti-His
antibody (top gels). An in vitro kinase assay was performed using GST–IB␣(1–56) as substrate (middle gels). IKK␤ protein levels were determined with an anti-Flag antibody (lower gels).

To further confirm that Hsp70 associated with IKK␥
within cells, we performed a two-hybrid assay in cultured mammalian cells. Hsp70 and Hsp70C CDNAs
were in frame cloned into the pM vector containing the
Gal-4 DNA-binding domain. Similarly, the IKK␥ and its
mutants, and IKK␣, IKK␤, and IB␣ CDNAs were in
frame inserted into pVP16 plasmid containing the activation domain. The resulting constructs were cotransfected into Cos-1 cells with a Gal-4 reporter gene. The
results confirmed the in vitro binding data showing
Hsp70 interaction with IKK␥ and IKK␥C1 but not with
IB␣, IKK␣, or IKK␤ (Fig. 3D). Hsp70C did not associate
with any of the molecules tested (Fig. 3D).
To determine whether endogenous Hsp70 interacted
with IKK␥ at physiologically relevant levels, we exposed
cells to heat and TNF, either with GFPsiRNA (control,
Fig. 3E, lanes 1–3) or with Hsp70siRNA (Fig. 3E, lanes
4–6). The cells were lysed and immunoprecipitated with
an anti-Hsp70 antibody. The amounts of IKK␥ protein in
the anti-Hsp70 immunoprecipitates were assessed with
anti-IKK␥ antibody (Fig. 3E). Portions of the total cell
extracts were immunoblotted with ␤-actin antibody as a
control for lane loading or for siRNA specificity. The
results confirmed that detectable amounts of endogenous IKK␥ were present in the anti-Hsp70 immunoprecipitates (Fig. 3E, second gel from top) but not in the
antiserum control (Fig. 3E, lane 1). In addition, IKK␥ specifically associated with endogenous Hsp70, as the
Hsp70–IKK␥ interaction was markedly decreased in
Hsp70siRNA transfectants (Fig. 3E, second gel from top,
lanes 4–6). IKK activity was analyzed next using an antiphospho-IB␣ (P-IB␣) antibody. As expected, elimination of Hsp70 by RNAi rescued heat-mediated inhibition
of IB␣ phosphorylation (Fig. 3E, top gel, lanes 3–6). Conversely, using a similar approach, the endogenous Hsp70
could also be detected in the anti-IKK␥ immunoprecipitates (Fig. 3F, second gel from top, lanes 2–4) but not in
the antiserum control (Fig. 3F, lane 1). IKK activity, as

To define the interactions of the components of IKK and
the effects of Hsp70 on the IKK complex in detail, we
used the mammalian two-hybrid system to determine
whether Hsp70 not only bound IKK␥, but also disrupted
interactions between the three IKKs. IKK␣, IKK␤, and
IKK␥ cDNAs were inserted in-frame into the pM plasmid containing Gal-4 DNA-binding domain and pVP16vector-bearing activation domains, respectively. Cos-1
cells were cotransfected with Gal-4-dependent luciferase
and IKK constructs. These data showed that IKK␣, IKK␤,
and IKK␥ formed homocomplexes (IKK␣/␣, IKK␤/␤,
IKK␥/␥) and heterocomplexes (IKK␣/␤, IKK␣/␥, IKK␤/␥),
and these complexes were disrupted in Hsp70 overexpressing cells (Fig. 4A).
To determine the effects of Hsp70 on IKK complex
assembly and IKK activity, we transfected 293 cells with
His-Hsp70 or His-Hsp70C. The extracts were immunoprecipitated with an anti-IKK␥ antibody. The amounts of
IKK␣ and IKK␤ proteins in the anti-IKK␥ immunoprecipitates were detected with anti-IKK␣/␤ antibody
(Fig. 4B, second gel), and in vitro kinase assays were performed on the immunoprecipitated IKK complexes using exogenous GST–IB␣ fusion protein as substrate.
Transfection with Hsp70 (third gel from the top) abolished the robust activation of IKK in response to TNF
stimulation (Fig. 4B, uppermost gel) and decreased the
amounts of IKK␣ and IKK␤ proteins in the anti-IKK␥
immunoprecipitates (Fig. 4B, second gel from top).
IKK␣/␤ expressions were not changed (Fig. 4B, fourth gel
from top).
These data suggested that Hsp70 might inhibit the assembly of the IKK complex. To test this possibility, we
transiently transfected Hsp70- and Hsp70C-inducible
Hela cells with Flag-IKK␣, Flag-IKK␤, and HA-IKK␥ constructs for 48 h. Following challenge with TNF, cells
were extracted and subjected to gel filtration on a Superose 6 column. Each column fraction was immunoblotted with anti-Flag (IKK␣/␤), anti-HA (IKK␥), and anti-His
(Hsp70, Hsp70C) antibodies. IKK activity was measured
using an in vitro kinase assay. Hsp70 reduced the size of
the IKK complex and markedly increased the amounts of
IKK␥ in the lower molecular weight fractions (fourth
row) in comparison with those from Hsp70C (third row)
transfected cells (Fig. 4C). Both the HA-IKK␥ (fourth row)
and His-Hsp70 (sixth row) were detected in the same
column fractions migrating at ∼120 kDa, a finding consistent with stable Hsp70–IKK␥ heterocomplexes. As
shown earlier, Hsp70 inhibited IKK activity (Fig. 4C, bottom two rows).
Because these results suggested that the Hsp70–IKK␥
interaction was critically involved in regulating NF-B
signaling, we confirmed whether disruption of IKK␥–
Hsp70 interaction would be sufficient to overcome
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Figure 3. Hsp70 interacts with IKK␥. (A)
Hsp70 or Hsp70C was immobilized on His
beads and incubated with 35S-labeled
IKK␣, IKK␤, or IKK␥. After extensive
washing, bound proteins were analyzed by
SDS-PAGE. (B) Diagram of IKK␥ and the
truncation mutants used in this study. (C)
His beads alone or His-Hsp70 immobilized
on beads were incubated with 35S-labeled
IKK␥ and its truncation mutants. After extensive washing, the bound proteins were
analyzed by SDS-PAGE. (D) Two-hybrid
assays for protein–protein interactions in
living cells. Cos-1 cells were transiently
transfected with the Gal4-reporter together with the indicated constructs, and
luciferase activity was measured 24 h
later. (E) Interaction of endogenous Hsp70
and IKK␥. 293 cells were transfected with
increasing amounts of Hsp70 siRNA
(lanes 4–6) or control GFP–siRNA (lanes
1–3). After 48 h, cells were heated at 45°C
for 30 min. Sixteen hours later, cells were
treated for 15 min with TNF or vehicle.
Cell lysates were immunoprecipitated
with anti-Hsp70 antibody (IP) and then
immunoblotted with anti-IKK␥ antibody
(IB). The IKK activities were detected using the whole-cell extracts with anti-phospho-IB␣ antibody (IB, top gel). Hsp70 was
detected with an anti-Hsp70 antibody
(third gel from top). (F) Coimmunoprecipitation of endogenous IKK␥ and Hsp70. 293
cells were transfected with increasing
amounts of IKK␥ siRNA (lanes 3–6). After
48 h, the cells were treated with vehicle or
TNF (25 ng/mL) for 15 min. Cell lysates
were immunoprecipitated with anti-IKK␥
antibody and then immunoblotted with anti-Hsp70 antibody. The whole-cell lysates were immunoblotted with anti-IKK␥ and anti␤-actin antibodies. IKK activities were detected using the whole-cell extracts with anti-phospho-IB␣ antibody (top gel).

Hsp70-mediated NF-B suppression. Because Hsp70 directly bound both IKK␥ and IKK␥C1, but not IKK␥C2
(Fig. 3C,D), we used IKK␥C1 to selectively disrupt the
interaction between IKK␥ and Hsp70 by competing for
binding to Hsp70. Therefore, 293 cells were transfected
with HA-IKK␥ and increasing amounts of HA-IKK␥C1 or
HA-IKK␥C2. Cells were exposed to TNF to activate NFB and exposed to heat shock (45°C) for 30 min to induce
endogenous Hsp70, and cell extracts were immunoprecipitated with anti-Hsp70 antibody. Appreciable
amounts of HA-IKK␥ protein could be detected with
anti-HA antibody in the anti-Hsp70 immunoprecipitates
(Fig. 4D, top gel, lanes 3–5) but not in the antiserum
control (Fig. 4D, top gel, lane 1). Another portion of these
cells was transfected with an NF-B reporter gene for
NF-B activity analysis. Immunoprecipitation showed
that Hsp70 interacted with IKK␥ and that IKK␥C1 displaced IKK␥ from Hsp70 immunocomplex (Fig. 4D, top
gel, lanes 3–5,7–9). IKK␥C1-mediated IKK␥ release from
the Hsp70–IKK␥ complex was accompanied by gradual
restoration of NF-B activity (Fig. 4D, upper panel, lanes
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7–9), whereas IKK␥C2 had no such effect (Fig. 4D, upper
panel, lanes 3–5).
Hsp70 precludes IKK␥ oligomerization,
which is required for NF-B activation
These data showed that IKK␥ formed homo-oligomers
(Fig. 4A) and that the coiled-coil motif of IKK␥ was the
Hsp70-binding site (Fig. 3B,C), suggesting that the
coiled-coil region serves as an effector domain to regulate the IKK complex via its oligomerization. If this conclusion is correct, the coiled-coil deletion mutant of
IKK␥ should not self-associate and should suppress NFB signaling. We tested this by transfecting Cos-1 cells
with IKK␥CC (the coiled-coil deletion mutant of IKK␥,
Fig. 3B) and either Gal4- or NF-B-dependent reporters.
The IKK␥CC failed to interact with itself or IKK␣ and
IKK␤, even on TNF treatment (Fig. 5A). In addition, the
IKK␥CC, like Hsp70, inhibited TNF-mediated NF-B activation (Fig. 5B). These effects of Hsp70 and IKK␥CC on
suppressing TNF-mediated NF-B activation are specific
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Figure 4. Hsp70 disrupts formation of the IKK complex. (A) Two-hybrid experiment. Cos-1 cells were transfected with Gal4-Luc
together with the indicated constructs in the figure and in Materials and Methods. Cells were subjected to luciferase analysis 24 h later.
(B) Hsp70 disrupts the IKK complex. 293 cells were transfected with His-Hsp70 or His-Hsp70C. After transfection for 48 h, the cells
were treated with vehicle or with TNF (25 ng/mL) for 15 min. After immunoprecipitation (IP) with anti-IKK␥ antibody, the IKK
activity was analyzed by in vitro kinase assay using GST–IB␣ (1–56) as substrate (top gel). The level of IKK␣/␤ present in the
immunocomplexes was immunoblotted with anti-IKK␣/␤ antibody (second gel from top). Expression of Hsp70, Hsp70C, and IKK␣/␤
are shown using anti-His and IKK␣/␤ antibodies from whole-cell extracts (third and fourth gels). (C) Hsp70 or Hsp70C stable Hela cells
were transiently transfected with Flag-IKK␣, IKK␤, and HA-IKK␥. After 48 h, cells were lysed and applied to a Superose 6 column. The
fractions were subjected either to immunoblotting (top six gels) or in vitro kinase assays using the GST–IB␣ (1–56) as substrate (lowest
two gels). (D) 293 cells were transfected with the same amounts of HA-IKK␥ (second gel) and increasing amounts of HA-IKK␥C1 (lanes
7–9) or IKK␥C2 (lanes 3–5) constructs. Twenty-four hours later, the cells were heated at 45°C for 30 min. After 16 h, the cells were
treated for 15 min with TNF or vehicle. The cell lysates were immunoprecipitated with anti-Hsp70 antibody and then immunoblotted
with anti-HA-IKK␥ antibody (top gel). The total expression levels of IKK␥, IKK␥C1, IKK␥C2, and Hsp70 in the whole-cell lysates were
immunoblotted with the appropriate antibodies. A portion of these cells was transiently transfected with an NF-B-dependent reporter
and Luciferase assays (top panel), performed as described in Materials and Methods 24 h after TNF treatment.

because our previous data showed that neither Hsp70C
nor Hsp70N affected NF-B activity (Fig. 1A). These data
suggested that IKK␥ oligomerization via the coiled-coil
motif was indispensable for IKK activity.
To further examine the effects of Hsp70 on IKK␥ oligomerization and its regulation of IKK activity, we transfected 293 cells with HA-IKK␥CC or HA-IKK␥. Some of
the cells were cotransfected with Hsp70 or Hsp70C. All
cells were metabolically labeled with 35S-methionine
and some were then briefly exposed to TNF. In vivo
chemical cross-linking experiments in 293 cell extracts
were performed using the homobifunctional cross-linker
ethyleneglycol-bis-succinimidylsuccinate (EGS), then
were immunoprecipitated with anti-HA antibody or
with anti-IKK␣/␤ antibody (for IKK␥-depleted extracts).
Some extracts were immunodepleted with an anti-IKK␥
antibody prior to immunoprecipitation. To analyze the

oligomeric state of IKK␥, we analyzed the cross-linked,
immunoprecipitated complexes by SDS-PAGE. We
readily detected the different IKK␥ oligomeric states
with masses of >250 kDa (Fig. 5C, lane 3), which was not
the case for IKK␥CC transfected cells (Fig. 5C; lanes 1,2).
The IKK␥ multimers containing the IKK␣/␤ complexes
may be necessary for basal NF-B activity (Fig. 5C, lane
3). TNF treatment resulted in formation of the high-molecular-weight IKK complex (Fig. 5C, lanes 4,7), whereas
immunodepletion of IKK␥ and transfection with Hsp70
markedly decreased the amount of the high-molecularweight IKK complex (Fig. 5C, lanes 5,6). To determine
whether the catalytic activity of the IKK complex required IKK␥ oligomerization, we retrieved IKK complexes from the transfected cells by immunoprecipitation with anti-HA/IKK␥ antibody or anti-IKK␣/␤ antibody and examined them for in vitro kinase activity.
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Figure 5. Hsp70 inhibits the IKK␥ oligomerization required for NF-B activation. (A) Two-hybrid experiment for protein interactions. Cos-1 cells were transiently transfected with
a Gal-4-dependent reporter and the indicated constructs and then subjected to luciferase analysis 24 h later. (B) IKK␥CC and Hsp70 inhibit TNF-induced (25 ng/mL) NF-B
activation. Cos-1 cells were transfected with NF-B-Luc together with either IKK␥CC or Hsp70 and then subjected to luciferase analysis 24 h later. (C) IKK␥ formed oligomers.
293 cells expressing HA-IKK␥ (lanes 3–7) or HA-IKK␥CC (lanes 1,2) were labeled with 35S-methionine. Some of the cells were transfected with Hsp70 (lane 6) or Hsp70C (lane 7)
expression vectors. Cells were treated with vehicle or TNF (25 ng/mL). Cells were lysed and the extracts were incubated with cross-linker (EGS). After cross-linking, one batch
had IKK␥ immunodepleted using IKK␥ antibody (lane 5). IKK␥ was immunoprecipitated with HA antibody (lanes 1–4,6,7), and the IKK␥ immunodepleted extracts were immunoprecipitated with an anti-IKK␣/␤ antibody (lane 5). The pellets were washed and analyzed by SDS-PAGE. IKK activity (KA) in the immunoprecipitates was determined with
GST–IB␣ as substrate (bottom gel). (D) Hsp70 inhibits the IKK␥ oligomerization in vitro. 35S-labeled IKK␥ and IKK␥CC were incubated with or without purified Hsp70 and the
cross-linking agent (EGS). The proteins were analyzed by SDS-PAGE. (E) IKK␥ or IKK complexes can be visualized in vivo and are inhibited by Hsp70 or heat. GFP–IKK␥,
GFP–IKK␥CC, or RFP–Hsp70 were expressed alone (panel a) or together (panels b,c) in Hela cells. Nontransfected cells were exposed either to vehicle (panel d), TNF (25 ng/mL
for 15 min; panel e), or TNF (25 ng/mL for 15min) plus heat (30 min at 45°C; panel f). They were then fixed and double immunostained with anti-IKK␥ and anti-IKK␣/␤ antibodies,
and fluorescent signals were visualized by confocal microscopy.
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Only IKK␥ transfected cells that were treated with TNF
had high IKK activity (Fig. 5C, lanes 4,7). IKK activity
was greatly decreased in TNF-treated cells by IKK␥CC
transfection (Fig. 5C, lane 2), by Hsp70 cotransfection
(Fig. 5C, lane 6), and following IKK␥ depletion (Fig. 5C,
lane 5). These results indicate that inducible IKK activity
is critically dependent on IKK␥ or its oligomerization.
These in vivo data also suggest that overexpression of
Hsp70 but not Hsp70C blocks formation of the IKK complex and favors formation of Hsp70–IKK␥ heterodimers
(Fig. 5C, lane 6).
Therefore, we next determined whether Hsp70 would
block IKK␥ oligomerization in vitro and whether IKK␥
oligomerization was dependent on any other proteins.
35
S-labeled HA-IKK␥ protein and purified Hsp70 were
cross-linked with EGS followed by anti-HA antibody immunoprecipitation. Cross-linked, immunoprecipitated
IKK␥ yielded additional species with molecular weights
corresponding to IKK␥ dimers, trimers, and tetramers,
with these multimers being dose-dependently inhibited
by addition of Hsp70 (Fig. 5D). This occurred because
Hsp70 associated with monomeric IKK␥ to form heterodimers (Fig. 5D, lanes 3–5). These in vitro experiments support the idea that Hsp70 inhibited formation
of the IKK complex by blocking oligomerization of IKK␥.
Although these data show that Hsp70 is sufficient to
prevent IKK␥ oligomerization in vitro, future studies
will be needed to determine whether Hsp70 blocks IKK␥
oligomerization in vivo.
To further confirm the effects of Hsp70 on IKK␥ or IKK
complex in living cells, we transfected GFP/IKK␥ (GFP,
green fluorescent protein), GFP/IKK␥CC, and RFP/
Hsp70 (RFP, red fluorescent protein) into Hela cells as
reporters and examined their subcellular localization using confocal microscopy. Expression of GFP/IKK␥ demonstrated multifocal, punctate regions of staining. They
could be macromolecular foci composed of either IKK␥
oligomeric complexes and/or complexes of IKK␥ with
other proteins. This contrasted with IKK␥CC expression,
which showed diffuse, uniform fluorescence (Fig. 5E,
panel a). These findings were observed in >95% of the
cells in which GFP/IKK␥ or GFP/IKK␥CC was expressed.
Cotransfection of GFP/IKK␥ and RFP/Hsp70 resulted in
a dramatic redistribution of IKK␥ from discrete macromolecular foci to uniform fluorescence (Fig. 5E, panel
c)—the findings being observed in >60% of cells in which
both GFP/IKK␥ and RFP/Hsp70 were coexpressed (in
some cells, the levels of Hsp70 expression may be not
sufficient for the redistribution of IKK␥). In nontransfected cells, double labeling with antibodies to IKK␥ and
IKK␣/␤ again showed macromolecular foci in TNFtreated cells (Fig. 5E, panel e), whereas there were no
IKK␥/IKK foci in control (no TNF treatment, Fig. 5E,
panel d) or heat-shocked (Fig. 5E, panel f) cells (Fig. 5E)—
the findings again being observed in >95% of cells. These
data represent a clear in vivo demonstration of the ability of Hsp70 to inhibit formation of these IKK␥ immunostained foci. The data are consistent with Hsp70 interfering with the formation of IKK␥ oligomers (dimers,
trimers, tetramers), and/or with Hsp70 interfering with

the association of IKK␥ with other proteins that make up
the IKK macromolecular complex.
Hsp70 promotes TNF-mediated cell death
Because Hsp70 suppression of NF-B activity could adversely affect cell survival, we investigated the effects of
Hsp70 on cell survival following treatment with several
stressors. We compared the apoptotic behavior of control
Hela cells to IB␣DN (IB␣DN-dominant negative used
to block NF-B activation) and Hsp70 stable Hela cells.
In many of the experiments, the cells were exposed to
TNF for 4 h and/or heating to 45°C for 30 min. Cell death
was detected by examination of the nuclear morphology using Hoechst staining. Normal cell survival was
observed for cells with vector alone, vector + TNF,
Hsp70C + TNF, or Hsp70, or when heated alone (Fig.
6A). Cell death, manifested by nuclei with intensely condensed and occasionally fragmented morphology, was
observed with cells treated with TNF plus any of the
following three treatments: overexpressing IB␣DN,
overexpressing Hsp70, or heating (Fig. 6A).
Quantitative evaluation of Hela cell survival showed
that treatment of Hela cells with LPS, PMA, staurosporine (STS), and serum deprivation decreased cell survival
from 100% to 40% or less. In contrast, nearly 95% of the
cells survived when treated with TNF alone (Fig. 6B, left
panel). Following expression of Hsp70, however, cell survival following LPS, PMA, STS, and serum deprivation
increased to 60%, whereas TNF treatment plus Hsp70
decreased survival from 95% (Fig. 6B, left panel) to ∼50%
(Fig. 6B, middle panel). Expression of Hsp70C combined
with TNF treatment was associated with nearly normal
95% cell survival (Fig. 6B, right panel), similar to the cell
survival with TNF treatment alone (Fig. 6B, left panel).
In a second experiment designed to examine the effects of NF-B and dose-dependent changes of Hsp70 and
Hsp70C on cell survival, treatment of control Hela cells
(empty vector) with TNF plus 0.01–0.25 mM ZnCl2 decreased cell survival from 100% to roughly 80% (Fig.
6C). In cells stably expressing IB␣DN, increasing induction of IB␣DN with increasing doses of ZnCl2 decreased
cell survival from 73% down to 22% after TNF treatment; and, in cells stably expressing Hsp70, increasing
induction of Hsp70 with increasing doses of ZnCl2 decreased cell survival from 75% down to 35% after TNF
treatment. Importantly, cells stably expressing
Hsp70C—which does not block NF-B activation—had
near normal survival with increasing doses of ZnCl2
from 78% up to 95%. It is notable that for both the Hela
cells stably expressing the vector pMEP4 and for the cells
stably expressing Hsp70C, increasing doses of ZnCl2 actually improved cell survival by a small but significant
amount in both cases. The explanation for this is not
clear, because increasing ZnCl2 doses induce endogenous Hsp70 to a modest degree (Fig. 1D). It is possible
that the ZnCl2 induces additional heat shock or other
stress proteins that protect the Hela cells by a small
amount in all of the experiments shown. In the case of
the vector and Hsp70C-expressing cells, the small pro-
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Figure 6. Effects of Hsp70 and NF-B on cell survival. (A) Hsp70-, Hsp70C-, and IB␣DN-inducible Hela cells were treated with ZnCl2 (100 µM) for 4 h. Sixteen hours later, the
cells were treated with vehicle or TNF (50 ng/mL) for 4 h. Nuclei were stained with Hoechst. (B) Hsp70- or Hsp70C-inducible Hela cells had Hsp70 (middle panel) or Hsp70C (right
panel) induced with ZnCl2 (100 µM) for 4 h. Sixteen hours later, all cells were treated with the indicated agents. Cell viability was assessed 24 h later using MTT. (C) IB␣DN-,
Hsp70-, or Hsp70C-inducible Hela cells, or cells with empty vector (pMEP4), were treated with increasing concentrations of ZnCl2 for 4 h. Sixteen hours later, cells were treated
with vehicle or TNF (50 ng/mL). Cell viability was assessed 24 h later using MTT. (D) NF-B rescues Hsp70–TNF-induced cell apoptosis. Hsp70-inducible Hela cells were
transiently transfected with an NF-B/p65 expression vector. Twenty-four hours later, the cells were treated with ZnCl2 (100 µM) for 4 h to induce Hsp70. TNF (50 ng/mL) or
vehicle was then added and cell viability assessed 24 h later using MTT. (E) IKK␥ overcomes TNF–Hsp70-induced cell apoptosis. Hsp70-inducible Hela cells were transiently
transfected with IKK␥ or IKK␥CC or empty vector. Twenty-four hours later, the cells were treated with vehicle or with ZnCl2 (100 µM) for 4 h to induce Hsp70. Sixteen hours
later, TNF (50 ng/mL) or vehicle was added and cell viability assessed 24 h after that using MTT. (F) IB␣DN-, Hsp70-, or Hsp70C-inducible Hela cells were treated with ZnCl2
(100 µM) for 4 h. Sixteen hours later, cells were then treated with vehicle or TNF (50 ng/mL). Twenty-four hours later, Western blots were performed on cell extracts with
antibodies to PARP, IB␣, and ␤-actin. NF-B activity was assessed in cells under the same conditions using a luciferase assay (bottom panel). (G) The effects of Hsp70–IKK␥
interactions on IKK activity and cell survival. HA-IKK␥ or Hsp70 siRNA (lanes 8,9) or GFPsiRNA (lanes 1–4,6,7) were transiently transfected into 293 cells. After 48 h, the cells
were treated either with vehicle, with TNF (50 ng/mL), and/or with heat (30 min at 45°C). Cells were lysed immediately, and the lysates immunoblotted with anti-phospho-IB␣
(top gel), anti-Hsp70 (second gel down), anti-IKK␥ (third gel down), and ␤-actin antibodies. The survival of similarly treated cells was determined 24 h later using MTT. (H) Hsp70
inhibits FLIP and IAP-2 expression. 293 cells were transiently transfected with His-Hsp70- or HA-IKK␥-expressing constructs. Forty-eight hours later, cells were treated with
vehicle or TNF, and FLIP and IAP-2 expression were assayed by immunoblots 24 h later.
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tective effects of these ZnCl2-induced stress proteins are
observed; however, in the IB␣DN and Hsp70-expressing
cells, the combined lethal effects of increasing amounts
of IB␣DN and Hsp70 plus TNF treatment lead to significant cell death and the small protective effects of
ZnCl2 are overwhelmed.
These results suggest that elevated Hsp70 sensitized
cells to TNF killing by interfering with NF-B signaling.
If this were the case, activation of NF-B would be expected to decrease apoptosis following combined exposure to Hsp70 and TNF. Hsp70 zinc-inducible cells were
transiently transfected with NLS/p65 construct. Indeed,
increasing levels of p65 improved cell survival following
zinc induction of His-Hsp70 and TNF treatment (Fig.
6D). To provide further evidence for this, we reversed the
improved cell survival obtained with increasing levels of
IKK␥ by the IKK␥ coiled-coil deletion mutant, IKK␥CC
(Fig. 6E).
To examine the mechanism by which Hsp70 inhibition of NF-B signaling leads to cell death, we determined whether elevated Hsp70 favored TNF-mediated
caspase activation via inhibiting the NF-B pathway.
The effects of Hsp70 and IB␣DN on caspase-3 processing were examined. The results showed that Hsp70 and
IB␣DN, but not Hsp70C, decreased TNF-induced NFB activity (Fig. 6F, lower panel). In addition, Hsp70 and
IB␣DN significantly enhanced TNF-induced PARP
cleavage (Fig. 6F, topmost gel).
Enforced expression of p65/NF-B or IKK␥ did not entirely rescue Hsp70-mediated cell death (Fig. 6C,D). This
might be due to the low efficiency of transient transfection in Hela cells (∼30%, data not shown). Additionally,
Hsp70AS did not appear to block Hsp70 function efficiently (Fig. 1A,E). We therefore performed additional
studies in 293 cells, where much higher rates of transfection could be obtained (∼90%–95% rate of transfection, data not shown). The 293 cells were transfected
with IKK␥ and Hsp70 siRNA or control GFPsiRNA for 2
d and then exposed to heat (30 min at 45°C) and/or TNF
(50 ng for 15 min). IKK␥ activity was detected using an
anti-P-IB␣ antibody. Cell survival was measured using
MTT 24 h after heat and/or TNF treatment. Treatment
with GFPsiRNA alone, TNF plus GFPsiRNA, or heat
shock plus GFPsiRNA did not affect cell survival (Fig.
6G, lanes 1–3). The combination of TNF treatment and
heat shock, however, decreased cell survival to ∼30%
(Fig. 6G, lanes 4,7). Overexpression of HA-IKK␥ (confirmed with HA-IKK␥ antibody; Fig. 6G, third gel from
top, lanes 5,6) enhanced IB␣ phosphorylation (Fig. 6G,
top gel, lanes 5,6) and increased cell survival to near control levels of 90% (Fig. 6G, top panel, lanes 5,6). Similarly, transfection of cells with Hsp70 siRNA almost reversed heat-shock-mediated IKK inhibition (Fig. 6G, top
gel, lanes 7–9) and increased cell survival levels to near
control levels of 90% despite combined heat shock and
TNF treatment (Fig. 6G, top panel, lanes 7–9). Lanes 4
and 7 in Figure 6G are replicates of each experiment and
are not duplicates.
Because Hsp70 inhibits NF-B transactivation and promotes caspase activation during TNF signaling (Fig. 6F),

it is proposed that Hsp70 would block endogenous NFB-dependent antiapoptotic gene expression. Indeed, the
results show that expression levels of cFLIP and IAP-2,
two antiapoptotic proteins (Fig. 6H, upper two gels), decreased in TNF-treated 293 cells with increasing levels
of His-Hsp70 protein. This Hsp70-mediated decrease of
cFLIP and IAP-2 expression was IKK␥ dependent because
increasing IKK␥ levels significantly reversed this (Fig.
6H, last three lanes).
Discussion
This study demonstrates how Hsp70 negatively regulates NF-B, thus establishing the first direct, mechanistic link between Hsp70 and the NF-B signaling cascade.
The Hsp70 decrease of NF-B activity tips the balance
from cell survival to cell death following TNF/death receptor stimulation (Fig. 7). The ability of Hsp70 to inhibit NF-B signaling may contribute to the enhanced
sensitivity of heated cells to chemotherapeutic agents
and radiation treatment, and it helps explain at least
some of the previous reports that demonstrate the proapoptotic effects of heat shock and Hsp70.
Hsp70 inhibits NF-B activation by binding IKK␥
Previous studies have shown that Hsp70 and heat shock
modulate NF-B function, but the mechanism by which
Hsp70 inhibits NF-B remained unclear (Feinstein et al.
1997; Guzhova et al. 1997; Curry et al. 1999; Andres et

Figure 7. Proposed pro-apoptotic role of Hsp70 in TNF-mediated apoptosis. TNF simultaneously activates caspase-8 and
NF-B (Micheau and Tschopp 2003). Hsp70 directly targets the
coiled-coil domain of IKK␥ and impairs TNF-triggered NF-B
activation. This occurs by binding of Hsp70 to IKK␥, which
prevents formation of the IKK complex and blocks TNF-triggered NF-B activation. Additionally, Hsp70 cannot block
caspase-8-mediated cell apoptosis (Beere et al. 2000). Therefore,
once Hsp70 levels are sufficient to significantly block the formation of the IKK complex, this plays an important role in
shifting cells from survival to death in response to TNF challenge.

GENES & DEVELOPMENT

1475

Downloaded from genesdev.cshlp.org on July 28, 2021 - Published by Cold Spring Harbor Laboratory Press

Ran et al.

al. 2002; Malhotra et al. 2002). In the present study, we
clarify the mechanism by which Hsp70 inhibits NF-B.
Our data demonstrate that Hsp70 directly binds to IKK␥
and this inhibits formation of the IKK complex and
blocks NF-B activation.
IKK␥ contains several distinct domains that are involved in regulating IKK activity (Rothwarf et al. 1998;
May et al. 2000; Yamamoto et al. 2001). The interaction
of IKK␥ with IKK␣ and IKK␤ is critical for the assembly
of the high-molecular-weight IKK complex that activates
NF-B, and IKK␥ appears to function as an adaptor protein to increase the interactions of key factors required
for NF-B activation (Yamaoka et al. 1998). IKK␥ is an
essential component of the IKK signalsome, as demonstrated in IKK␥-deficient or IKK␥ mutant cells, which are
unable to trigger the NF-B response to a wide array of
stimuli (Rothwarf et al. 1998; May et al. 2000; Rudolph
et al. 2000; Makris et al. 2002). The large 700–900-kDa
IKK complex does not form in cells lacking IKK␥ (Yamaoka et al. 1998). A variety of proteins that interact
with IKK␥, including RIP, A20, Tax, CIKS, vCLAP, and
CYLD are involved in regulating NF-B signaling (Jin et
al. 1999; Leonardi et al. 2000; Poyet et al. 2000, 2001;
Zhang et al. 2000; Brummelkamp et al. 2003). We postulate and verify the possibility that Hsp70 binds IKK␥ to
hamper IKK activation. Our results show that Hsp70–
IKK␥ interaction plays a key role in NF-B signaling.
It has been well characterized that the coiled-coil domain of IKK␥ is responsible for IKK␥ oligomerization,
which is critical for activating IKK activity (Poyet et al.
2000). The results of this study show that Hsp70 specifically binds the coiled-coil domain of IKK␥. These findings agree, at least in part, with those of Agou et al.
(2002) who have shown that IKK␥ (NEMO) binding via
the coiled-coil domain to Hsp70 prevents incorrect interdomain pairing reactions. In the present study, we
suggest that excess Hsp70 binding to IKK␥ may prevent
IKK␥ self-association that is critical for the formation of
the high-molecular-weight IKK complex. Hsp70 binding
to the coiled-coil domain of IKK␥ might lead to a chaperone-dependent change in the conformation of IKK␥. In
this case, IKK␥ does not form oligomers when bound to
Hsp70, and it is rendered inaccessible to the IKKs and
prevents assembly of the IKK complex. Because IKK activity is markedly impaired in cells that express IKK␥CC
or Hsp70, and enforced oligomerization of IKK␥ was able
to activate NF-B (Poyet et al. 2000), these data indicate
that IKK␥ oligomerization is absolutely essential for
TNF-induced NF-B activation (Tegethoff et al. 2003).
Although strong evidence is provided that Hsp70 targeting to IKK␥ plays a negative role in NF-B signaling,
the data do not rule out the possibility that Hsp70 may
interact with other components of the IKK complex. The
gel filtration data show that Hsp70 is detected in fractions in addition to the IKK␥ fractions (200–500 kDa).
Future studies will be required to examine the possibility that Hsp70 could have other targets in this pathway.
Interestingly, we found that IKK␥ can be directly visualized in macromolecular foci in living cells, which is in
line with previous reports (Poyet et al. 2000; Heussler et
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al. 2002). Moreover, overexpression of Hsp70 or heat
treatment significantly suppresses these macromolecular foci. These findings could suggest that Hsp70 inhibits
these foci by preventing IKK␥ oligomerization or Hsp70
suppresses these foci by inhibiting IKK␥ binding to other
proteins in the IKK complex.
Although Hsp70 did not bind directly to either IKK␣ or
IKK␤ (Fig. 3A), Hsp70 still influenced the formation of
IKK␣ and IKK␤ hetero- and homocomplexes (Fig. 4A). It
is likely that Hsp70 indirectly regulates the assembly of
the IKK complex via interacting with IKK␥. Because
IKK␥ is a component of the IKK␣ and IKK␤ hetero- and
homocomplexes (Yamaoka et al. 1998; Mercurio et al.
1999), the formation of these complexes may be IKK␥
dependent. Several reports demonstrate that IKK␥ is required to facilitate the interactions of the IKK complex
as a whole and/or that it influences individual components of the IKK complex (Mercurio et al. 1999; Poyet et
al. 2000; Yamamoto et al. 2001). The exact mechanism
remains to be elucidated.
The finding that transfection of Hsp70 siRNA into 293
cells restores IKK activity is strong evidence, along with
the other experiments shown, that Hsp70 directly regulates IKK activity. However, it is notable that complete
elimination of Hsp70 expression with Hsp70 siRNA (Fig.
3E, lane 6) did not increase IKK activity over the nonheat-shock control, where moderate amounts of Hsp70
were present (Fig. 3E, lane 2). This suggests that other
heat shock proteins could also down-regulate IKK activity. Indeed, it has recently been shown that Hsp27 binds
IKK␤ and inhibits NF-B activity (Park et al. 2003). The
situation is even more complex because Hsp90 can also
bind the kinase domain of IKK␣ or IKK␤ to form part of
the ∼900-kDa IKK complex (Chen et al. 2002). However,
Hsp90 binding increased TNF-mediated NF-B activation, as shown in the present study (Fig. 1A). Therefore,
although heat shock down-regulates NF-B activity (Fig.
4D), this is likely due to a complex interaction of Hsp70–
IKK␥ and Hsp27–IKK␤ to down-regulate IKK activity,
whereas Hsp90–IKK␣ and Hsp90–IKK␤ interactions upregulate IKK activity. Because heat shock down-regulates NF-B activation (Fig. 4D), the effects of Hsp70 and
Hsp27 on down-regulation must overwhelm the up-regulation by Hsp90. In addition, the current studies demonstrate that although low levels of Hsp70 do not appear to
affect IKK activity a great deal, high-level Hsp70 expression significantly blocks IKK activity and markedly decreases NK-B activity.
Although the data show that Hsp70 specifically binds
the coiled-coil motif of IKK␥, the regions of Hsp70 responsible for this binding are less clear. Although the
ATP-binding domain of Hsp70 might be expected to bind
IKK␥, our data show that neither the N-terminal nor the
C-terminal domains of Hsp70 significantly affect NF-B
activity (Fig. 1A). This result is similar to a recent study
in which it was shown that full-length Hsp70 binds
Apaf-1, whereas neither Hsp70C nor Hsp70N could be
shown to interact with Apaf-1 (Ravagnan et al. 2001).
The results of our study and that of Ravagnan et al.
(2001) could suggest that full-length Hsp70 is essential
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for the interaction with some molecules such as IKK␥
and Apaf-1. This is not surprising because the ATP-binding domains and the peptide-binding domains of Hsp70
are functionally coupled each other and probably essential for the complete repertoire of physiological effects of
the molecule.
Hsp70 promotes apoptosis by blocking
NF-B-dependent gene expression
The discovery that Hsp70 suppressed NF-B activation
provides the first clear explanation for the pro-apoptotic
effect of Hsp70 on cell survival. TNF applied to the three
types of cells examined in this study activated NF-B but
did not produce apparent apoptosis, a finding consistent
with the recent report (Micheau and Tschopp 2003). TNF
applied to the same three cell types overexpressing
Hsp70 in this study, however, led to the failure to activate NF-B, decreased expression of NF-B antiapoptotic
genes such as c-FLIP and IAP-2, and activated caspase-3dependent cleavage of PARP. These findings are in stark
contrast with the effects of Hsp70 on mitochondrial-mediated apoptosis, in which Hsp70 inhibits cell apoptosis
by interfering with Apaf-1 and activation of caspase-3mediated apoptotic pathways (Beere et al. 2000). Hsp70
appears to facilitate apoptosis that is initiated by TNF
activation of its death receptors, with very high levels of
Hsp70 protein being required to sensitize cells to TNF
killing. These results are also generally consistent with a
study that demonstrated increased cell death following
inhibition of antiapoptotic genes (Goyal et al. 2000).
The death-promoting effect reported here for Hsp70 is
at variance with the commonly described protective effect of Hsp70. However, some reports show that heat
shock can also increase susceptibility to death, as occurs
for NK or LAK cells (Jaattela 1990; Fujieda et al. 1995). In
acute myeloid leukemia, apoptosis correlated with increased Hsp70 levels (Chant et al. 1996). A pro-apoptotic
function of Hsp70 itself has been described after TCR/
CD3 or CD95 activation in Jurkat cells overexpressing
Hsp70 (Liossis et al. 1997). Hsp70 was found to accelerate the caspase-activated DNase and DNA fragmentation in TCR-stimulated T-cell apoptosis (Liu et al. 2003).
It has been known for some time that heat produces
radiosensitization, in which prior heat shock increases
cell death in tumors produced by radiation (Dewey and
Freeman 1980; Dewey 1994). The adenovirus E1A sensitizes tumor cells to lysis by macrophages through nitric
oxide- and TNF-␣-dependent mechanisms, despite upregulation of Hsp70 (Miura et al. 2003). These data, together with our results, demonstrate that Hsp70 potentiates TNF-mediated cell apoptosis. Although Hsp70
generally prevents cell death, Hsp70 can promote cell
death when it is overexpressed in a cell that is also exposed to TNF and possibly other death-receptor molecules.
There is a report that TNF mediates susceptibility to
heat-induced apoptosis by TNF-induced inhibition of
Hsp70 expression (Schett et al. 2003). However, this is
inconsistent with the finding that TNF receptor I is re-

quired for induction of macrophage heat shock protein
70 (Heimbach et al. 2001). In addition, TNF induces
Hsp70 expression in cardiac myocytes (Nakano et al.
1996). Therefore, although TNF could down-regulate
Hsp70 in selected cells in certain circumstances (Schett
et al. 2003), our data and other studies do not find that
TNF inhibits HSF1/Hsp70 induction in most cells
(Schett et al. 1998; Heimbach et al. 2001). Instead, our
data show that TNF-induced cell death is mediated or at
least potentiated by Hsp70 down-regulation of NF-B
signaling in most cells. The differences in these results
might relate to differences in NF-B-mediated gene expression in different cell types, where NF-B mediates
cell survival in neuronal and most other cells, whereas
NF-B may mediate cell death in at least some cell types.
Although most studies, including the present one,
have shown that TNF and heat shock work synergistically to kill cells, the potential for sensitizing cells to
TNF killing by manipulating Hsp70 may not be applicable to all cells, as evidenced by at least one report
(Jaattela et al. 1998). The discrepancy between these
studies could be due to several experimental variables
that have not been controlled for. For instance, recent
data show that Hsp70 only temporarily protects against
TNF-mediated cell apoptosis and this protection is lost
after 16 h (Gabai et al. 2002). Although one study has
shown that Hsp70 inhibited TNF-induced ME180 cell
death (Jaattela et al. 1998), another has found that Hsp70
did not impede TNF-mediated ME180 cell apoptosis
(Ravagnan et al. 2001). It is certainly possible that elevated Hsp70 might protect cells from TNF-induced cell
death, particularly during early stages. However, very
high levels of Hsp70 do not favor cell survival when cells
are exposed to TNF challenge, at least in this study (Fig.
6A,C,G). In addition, the current study shows that the
Hsp70 effect on IKK␥ is dose related, with lower Hsp70
levels seemingly having little effect on IKK activity or
NF-B activation (Figs. 3E, 4D). Only very high levels of
Hsp70 protein decrease IKK activity (Fig. 4B), and the
highest Hsp70 protein levels are required for the greatest
TNF-induced apoptosis (Fig. 6B,C,G). It is worth emphasizing that even in the current study, Hsp70 enhances
TNF-induced apoptosis, but this did not occur for other
stimuli (Fig. 6B). Instead, Hsp70 provided modest protection against LPS-, PMA-, STS-, and serum deprivationinduced cell death (Fig. 6B). Taken together, these findings indicate that the overexpression of Hsp70 is capable
of either promoting or inhibiting apoptosis, depending
on the nature of the stimulus. Finally, even our data
suggest that zinc induction of other heat shock and other
stress proteins may protect, at least to some degree,
against TNF-induced cell death (Fig. 6C).
Our unique findings help explain a number of important and puzzling phenomena that heat shock or elevated Hsp70 potentiate TNF-, FasL- and radiation-mediated cell death. It is likely that this Hsp70–NF-B interaction is involved in a variety of disease conditions.
Clinical studies over a number of years have shown that
there is often an advantage for using heat combined with
radiation or cytotoxic drugs to enhance tumor cell kill-
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ing (Connor et al. 1977; Miller et al. 1977; Dewey and
Freeman 1980; Dewey 1984; Curry et al. 1999). We have
identified the structural requirement for the interaction
of Hsp70 with IKK␥ and shown that the coiled-coil domain of IKK␥ is necessary for TNF-triggered, Hsp70-dependent decrease of NF-B activation. The coiled-coil
domain of IKK␥ thus appears to be an attractive target for
drug development. Drugs like Hsp70 that target the
coiled-coil domain of IKK␥ might decrease NF-B activation during death-receptor stimulation and be clinically useful for enhancing tumor cell death or controlling inflammation.
Materials and methods
Cell culture
Hela, Cos-1 (ATCC), and 293 (Invitrogen) cells were grown in
DMEM medium (Gibco) supplemented with 10% (v/v) fetal calf
serum and 2 mM L-glutamine (Gibco). Hela Zn2+-inducible cell
lines were generated by transfection with pMEP4, pMEP4/HisHsp70, pMEP4/His-Hsp70C, and pMEP4/IB␣DN constructs.
The transfected cells were selected with hygromycin (Gibco) for
2 wk. The selected clones were incubated in medium with Zn2+
for 4 h to induce gene expression that was confirmed by Western
blot 24 h later.
Cell viability assays
The MTT assay was used to assess cell viability and was performed according to the directions in the manufacturer’s instruction manual (Sigma).
Plasmids and reagents
The following constructs were used in various experiments in
this study: pCMV/p65, pCMV4/IB␣DN (IB␣ dominant negative), pCR-Flag/IKK␣, pCR-Flag/IKK␤, pRC-HA/IKK␣, pRCFlag/IKK␤, pRC-HA/IKK␥, GST/IB␣ (1–56), and pcDNA3/
HSF1 (see Acknowledgments). Other plasmids were obtained
commercially: pBluescript/Hsp90, pAG153/Hsp70 (ATCC);
pSV/␤-galactosidase (Promega); Cal4-Luc, NF-B-Luc (Stratagene); and pMEP4 (Invitrogen). The mammalian two-hybrid system and pEGFP and pDsRed2 were obtained from Clontech and
pCruz HA was obtained from Santa Cruz.
The other plasmids were constructed by PCR or appropriate
restrictive-enzyme-digested methods: pcDNA3/Hsp90, pcDNA3/
Hsp70 antisense, pcDNA3/IB␣DN, pcDNA3/His-Hsp70N
(amino acids 1–420), pcDNA3/His-Hsp70C (amino acids 420–
640), pMEP4/IB␣DN, pMEP4/His-Hsp70, pMEP4/His-Hsp70C
(amino acids 420–640), pM/IKK␣, pVP16/IKK␣, pM/IKK␤,
pVP16/IKK␤, pM/IKK␥, pVP16/IKK␥, pM/IKK␥CC (deleted
amino acids 260–320, see Fig. 3B), pVP16/IKK␥CC, pM/IB␣,
pVP16/IB␣, pCruz/IKK␥, pCruz/IKK␥N (amino acids 1–100),
pCruz/IKK␥C1 (amino acids 250–419), pCruz/IKK␥C2 (amino
acids 320–419), pCruz/IKK␥CC, pM/p65AD, NLS/p65, GFP/
IKK␥, GFP/IKK␥CC, RFP/HSP70, pRSET/Hsp70, pRSET/
Hsp70C (amino acids 420–640).
Antibodies used included anti-His, phospho-IB␣ (Cell Signaling), ␤-actin and TRITC-conjugated IgG, Flag (Sigma), HA,
IB␣, IKK␣/␤ (which recognized both IKK␣ and IKK␤), IKK␥,
p65, c-FLIP, IAP-2 (Santa Cruz), and PARP (Oncogene). Chemicals used included STS, TNF, LPS, PMA, protein G agarose
beads, and Hoechst (Sigma). The TNT kit that was used for in
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vitro translation and the Luciferase kits were from Promega.
The SuperFect transfection kit was from Qiagen. The gel filtration column kit was from Amersham Pharmacia Biotech. The
[␥32P]ATP (3000 mCi/nmole) and [35S]methionine were from
Dupont/NEN and the cross-linker EGS was from Pierce Inc.
Transfection and gene silencing assays
Hsp70 siRNA, IKK␥ siRNA, and GFP siRNAs were generated as
follows. The recombinant dice enzyme was used to cleave in
vitro transcribed dsRNA into 22-bp siRNA according to the
instructions supplied by the Dicer siRNA Generation Kit (Gene
Therapy Systems, Inc).
The following primers were used for Hsp70: 5⬘-primer, 5⬘GCGTAATACGACTCACTATAGGGAGAATGCCCCCAGC
TACGTGGCCTTC-3⬘; and 3⬘-primer, 5⬘-GCGTAATACGACT
CACTATAGGGAGATAAAGCTTGGCGTCGCGCAGAG
C-3⬘.
The following primers were used for IKK␥: 5⬘-primer, 5⬘GCGTAATACGACTCACTATAGGGAGAATGTGCACCTG
CCTTCAGAACAG-3⬘; and 3⬘-primer, 5⬘-GCGTAATACGACT
CACTATAGGGAGATAACTGGAAGTCCGCCTTGGTAG-3⬘.
The following primers were used for GFP: 5⬘-primer, 5⬘-GC
GTAATACGACTCACTATAGGGAGAATGAAGCTGACCT
GAAGTTCATC-3⬘; and 3⬘-primer, 5⬘-GCGTAATACGACTC
ACTATAGGGAGATAATGATCGCGCGCTTCTCGTTG-3⬘.
Mammalian two-hybrid assays
IKK␣, IKK␤, IKK␥, IKK␥ mutants, IB␣, Hsp70, Hsp70N,
Hsp70C, and other constructs were in-frame inserted into the
mammalian two-hybrid vectors pVP16 and pM, respectively.
Cos-1 cells were cotransfected with these constructs and the
Gal4-Luc reporter gene and equal amounts of ␤-gal plasmid as
an internal control. Luciferase activity was measured 24 h after
transfections.
Reporter gene assays
Hela cell stable cell lines, 293 cells, and Cos-1 cells were seeded
into 24-well plates. On the following day, cells were transfected
using the SurpFect kit. Each well was transfected with 50 ng
NF-B-, AP-1-, or HSF-1-dependent luciferase reporters, 25 ng
pSV/␤-galactosidase as an internal control, and the desired constructs as described in the figures or in their legends. Twentyfour hours posttransfection, the cells were stimulated for 15
min with TNF. Twenty-four hours later, the cell extracts were
subjected to luciferase assays.
Electrophoretic mobility shift assay
EMSA was performed as previously described (Lu et al. 2002).
The 32P-labeled oligonucleotide AGTTGGGGACTTTCCCA
GG was used as the probe. Probe (2.5 ng), nuclear proteins (5 µg),
or the indicated amounts of in vitro translated proteins were
used as described in the figure legends.
In vitro protein interactions
Three microliters of 35S-labeled-IKK␣, IKK␤, IKK␥, and IKK␥
mutants and 0.25 µM of Hsp70 or Hsp70C previously immobilized on beads were incubated in binding buffer for 3 h at 4°C.
The mixtures were washed five times with wash buffer to remove nonspecifically bound proteins and then analyzed by SDSPAGE and autoradiography.
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Gel filtration chromatography
Gel filtration chromatography was carried out on a Superose 6
column. Hsp70 or Hsp70C stably expressing cells were transiently transfected with Flag-tagged IKK␣, Flag-tagged IKK␤,
and HA-tagged IKK␥. Cells (2 × 107) were washed with PBS.
Cells were collected, and S100 extracts were prepared as previously described (Poyet et al. 2000). The cell extracts were loaded
onto a Superose 6 column. The column was precalibrated with
the molecular mass marker proteins dextran (2000 kDa), thyroglobulin (670 kDa), ␤-amylase (230 kDa), and bovine serum albumin (66 kDa). Proteins were eluted from the column and
analyzed by SDS-PAGE followed by Western blotting for the
different IKK subunits and Hsp70 and Hsp70C using appropriate
antibodies. IKK activity of each fraction was measured using an
in vitro kinase assay.
Immunoprecipitation, immunoblotting, and kinase assays
Immunoprecipitation studies were performed as described by
Chen et al. (2002). Briefly, cells were collected and lysed in 500
µL lysis buffer. Cleared cell extracts were incubated in 2 µg/500
µL of the appropriate antibodies and 10 µL of protein-G agarose
beads for 3 h at 4°C. After the incubation, the precipitated complexes were washed five times and samples were boiled for 5
min in loading buffer, applied to SDS-PAGE, and analyzed by
Western blotting using appropriate antibodies. IKK␣/␤ was immunoprecipitated from cell extracts with the appropriate antibodies, as indicated in the figure legends. In vitro kinase assay of
the immunocomplexes was performed as described (Chen et al.
2002).
Chemical cross-linking of proteins
293 cells were cultured in DMEM without methionine for 1 h
and then labeled with 500 µCi of 35S-methionine per 60 mm
dish for 6 h. The cells were lysed in lysis buffer. Cross-linking
using EGS and immunoprecipitation were performed as recently described (Tegethoff et al. 2003). Cross-linking of in vitro
translated IKK␥ was performed using the same methods.
Confocal microscopy
Microscopy was performed using a Zeiss LSM-510 confocal microscope.
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